molnupiravir molnupiravir
Stories About

molnupiravir

A passer-by walks past a sign that calls attention to COVID-19 testing while departing a Walgreens pharmacy, Wednesday, Dec. 15, 2021, in New Bedford, Mass. (AP Photo/Steven Senne) Steven Senne/AP hide caption

toggle caption
Steven Senne/AP

'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited

  • <iframe src="https://www.npr.org/player/embed/1085078893/1085187970" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Merck's anti-viral drug molnupiravir isn't popular with doctors who prefer to prescribe another antiviral, Paxlovid. Merck & Co Inc. hide caption

toggle caption
Merck & Co Inc.

Doctors find limited use for less effective COVID pill

  • Download
  • <iframe src="https://www.npr.org/player/embed/1081898013/1082401670" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Thomas Hansmann/Pfizer

The COVID antiviral drugs are here but they're scarce. Here's what to know

  • Download
  • <iframe src="https://www.npr.org/player/embed/1069323181/1069739439" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript